Industry Veteran Ben Dudley Joins MMS as Chief Commercial Officer (CCO) to Drive Continued Growth for the Data-focused Clinical Research Organization
BRUSSELS, July 17 (Reuters) - Europe's second-top court on Wednesday said the European Commission did not give the public sufficient access to the purchase agreements for COVID-19 vaccines during the pandemic, upholding a challenge brought by EU lawmakers against the EU executive's handling of the deals.
AstraZeneca picks WPP as a primary creative partner in oncology
AstraZeneca’s Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been approved in the European Union (EU) for the 1st-line treatment of adult patients with advanced epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) whose tumours have exon 19 deletions or exon 21 (L858R) mutations.
AstraZeneca India Private Limited (AZIPL), the global capability centre (GCC) of British-Swedish drugmaker AstraZeneca, announced an investment of Rs 250 crore ($30 million) to expand its Global Innovation and Technology Centre (GITC) in Chennai.
AstraZeneca`s COVID prevention drug application gets EU fast-track assessment
Ethris’ mRNA-based treatment to prevent viral infections in people with uncontrolled asthma so far appears to be safe and increases expression of its target protein, early data suggest. nnThe German biotech announced June 25 interim phase 1 data on its lead candidate, ETH47, which indicate it successfully encodes the protein interferon lambda (IFN?) in healthy people. A full readout is expected in the third quarter of 2024.
China approves AZ`s Tagrisso-chemo combo as first-line treatment